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INTRODUCTION 49 50
The cardiovascular system is one of the first vertebrate organs to develop, and it is critical for the 51 delivery of oxygen and nutrients and the removal of waste products from developing and mature 52 organs (Marcelo et al., 2013) . Endothelial cells (ECs) constitute the building blocks of the 53 vasculature, lining the luminal side of all vessels. EC specification is a crucial event for the 54 development of the circulatory system and the lack of a vascular system leads to early embryonic 55 lethality in most animals (Lee et al., 2008) . In zebrafish, EC precursors were identified in the 56 ventral region of the gastrulating embryo as early as shield stage (Vogeli et al., 2006) . During 57 gastrulation, a subset of ventral mesodermal cells differentiates into angioblasts, the progenitor 58 of ECs. During somitogenesis, the angioblasts migrate from the lateral plate mesoderm (LPM) 59 towards the midline of the embryo, where they coalesce to form the axial vessels: the dorsal 60 aorta and the cardinal vein (Jin et al., 2007) . Sequential transcriptional waves orchestrate EC 61 differentiation starting from 6 hours post fertilization (hpf) and a number of transcription factor 62 genes have been described to be involved in this process, including cloche/npas4l (Stainier et al., 63 1995; Reischauer et al., 2016) , fli1 (Craig et al., 2015) , etv2 (Pham et al., 2007) , lmo2 (Weiss et 64 al., 2012) , sox7 (Hermkens et al., 2015) and tal1 (Bussmann et al., 2007) . Importantly, cloche 65 mutants exhibit a severe impairment of EC specification, lacking most endothelial and 66 hematopoietic tissues (Stainier et al., 1995) , and they fail to activate the EC specification 67 program (Liao et al., 1997; Ho et al., 1999) . 68
The role of cloche in EC specification was determined to be cell-autonomous (Parker and 69 Stainier, 1999) . For more than two decades, the cloche mutant has been employed as an 70 avascular model to study the impact of vasculature on the development of other organs, 71
including the retina (Dhakal et al., 2015) , the pancreas (Field et al., 2003a) and the liver (Field et 72 al., 2003b) . Since the cloche locus is situated in a telomeric region, the isolation of the gene was 73 challenging, and only recently, cloche was found to encode a bHLH-PAS transcription factor 74 (Reischauer et al., 2016) . The Cloche protein was thereafter called Npas4l due to its partial 75 similarity, in terms of amino acid sequence, to mammalian Npas4 (Reischauer et al., 2016) . 76
Interestingly, npas4l is present in fish, reptiles and birds, but is missing in mammals, raising 77 questions about its mammalian functional ortholog and the evolution of endothelial cell 78 differentiation (Reischauer et al., 2016) . 79
In this study, we identified genes downstream of Npas4l. We generated novel loss-and 80 gain-of-function models for npas4l and combined transcriptomic data with chromatin 81 immunoprecipitation (ChIP) of Npas4l to elucidate its molecular mechanism of action. Our data 82 indicate that Npas4l drives EC differentiation by inducing the expression of the transcription 83 factor genes etv2, tal1 and lmo2, directly binding to their promoters. Furthermore, the analyses 84 performed led to the identification of a potential new player in cardiovascular development. 85
Using the CRISPR/Cas9 technology, we generated a mutant for tspan18b, which we show is a 86 target of Npas4l. tspan18b mutants exhibit early angiogenic defects, confirming the reliability of 87 the datasets generated. Collectively, these data represent a valuable resource of Npas4l target 88 genes that may play a role in vascular and hematopoietic development. 89
90

RESULTS AND DISCUSSION 91
Npas4l promotes endothelial cell specification by directly inducing angioblast genes 92
In order to gain insight into the gene regulatory network controlled by Npas4l in vivo, we first 93 conducted an overexpression experiment by injecting npas4l mRNA into one-cell stage zebrafish 94 embryos. Following npas4l overexpression, we performed microarray analysis to identify 95 transcripts upregulated at 30 and 95% epiboly ( Fig. 1A) . Gene Set Enrichment Analysis (GSEA) 96 results showed that npas4l was sufficient to drive the expression of a number of genes involved 97 in blood vessel morphogenesis ( Fig. 1B) , consistent with previous data (Reischauer et al., 2016) . 98
As early as 4 hpf (30% epiboly), we detected the induction of angioblast and endothelial markers 99 including etv2, tal1 and lmo2 ( Table I) . These and other angioblast specific genes were 100 upregulated at both stages (Fig. 1C) . Additionally, we identified dnajb5, a gene encoding a 101 member of the heasthock 40 protein family, which was induced at 30 and 95% epiboly ( Fig.  102   S1A) . in situ hybridization analysis showed that dnajb5 is expressed in the LPM at the 5-somite 103 stage ( Fig. S1B) . Notably, genes expressed in mature endothelium such as kdrl, cdh5, she, and 104 clec14a, which have previously been reported to function downstream of Etv2 (Gomez et al., 105 2012), were substantially induced at 95% but not at 30% epiboly (Fig. 1C) . 106
The transcriptional analysis performed at two different time points provides insight into the 107 temporal dynamics of the transcriptional cascade initiated by Npas4l. We hypothesized that 108 genes upregulated at 30% epiboly may reflect direct targets, while those upregulated at 95% 109 epiboly represent indirect or secondary targets. In order to determine the direct downstream 110 targets of Npas4l, we performed a genome-wide chromatin immunoprecipitation sequencing 111 analysis (ChIP-Seq). Due to the lack of commercially available antibodies recognizing Npas4l, 112
we used an HA-tagged version of the protein that was able to induce expression of etv2 at similar 113 levels when compared to wild-type (WT) Npas4l (Fig. S1C) . We found that Npas4l-HA binds a 114 total of 42 genomic regions, 19 within 5 kb from a transcription start site (TSS) (Fig. S1D) , 6 in 115 intragenic regions and the remaining 17 in intergenic regions (Fig. 1E ). Next, we performed a 116 cross-analysis of genes induced at least 2-fold by overexpression of npas4l and genes whose TSS 117 is present within 100 kb from an Npas4l binding site, leading to the discovery of 15 genes that 118 are likely to be direct targets of Npas4l, including etv2, tal1, lmo2, egfl7, gata2a and tspan18b 119 ( Fig. 1D and S1E) . We also extrapolated the binding motif of Npas4l using the MEME Suite 120 online tool (http://meme-suite.org), and identified the consensus sequence TCGTGA (Fig. 1F) . 121
This binding motif is consistent with the non-palindromic binding sites reported for other bHLH-122 PAS transcription factors, including HIF-1α , characterized by the core sequence CGTG 123 (Schodel et al., 2011; Lo and Matthews, 2012) . In particular, the TCGTG site was found to be 124 the target of Dysfusion, the Drosophila ortholog of Npas4l (Jiang and Crews, 2007) , and the 125 same sequence was described to be the target of the neuronal-specific activity-dependent NPAS4 126 in mouse (Sorensen et al., 2016) . Intriguingly, Tsang et al. (2017) reported that HIF-1α binds to 127 the Etv2 promoter in human embryonic stem cells and that hypoxia promotes Etv2 expression via 128 HIF-1α. Considering the similarity of the HIF-1α motif to that of Npas4l ( Fig. 1F) , this bHLH-129 PAS transcription factor may, at least in part, have taken over npas4l function in mammals. 130
Transcriptomic and epigenomic analyses of the npas4l mutant 131
To better describe the molecular mechanisms of Npas4l function, we analyzed the transcriptome 132 and epigenome of npas4l mutants. Using CRISPR/Cas9 technology, we generated a new npas4l 133 mutant allele with a lesion in its second exon which encodes the bHLH domain ( Fig. S3) . 134 TgBAC(etv2:EGFP) ci1 npas4l -/exhibit a strong phenotype, comparable with the previously 135 described m39 (Stainier et al., 1995) and s5 (Liao et al., 2000) alleles, with the advantage that 136 this new allele (bns297) can be genotyped using high resolution melt analysis (Samarut et al., 137 2016) . Previous studies had analyzed the transcriptome of npas4l/cloche mutants at 15-and 18-138 somite stage (Qian et al., 2005; Sumanas et al., 2005) . However, in order to focus on the early 139 expressing genes, we performed RNA-sequencing (RNA-seq) analysis of mutant embryos and 140 their WT siblings at the 6-somite stage ( Fig. 2A) . tal1, etv2 and lmo2 were strongly 141 6 downregulated in the mutant embryos compared to WT siblings ( Fig. 2B, Table I ). The 142 expression levels of hematopoietic genes, including gfi1aa and gata1a, were also decreased in 143 the mutants, although these genes were not induced by npas4l overexpression (Fig. 2C) . Gene 144 set enrichment analysis highlighted a number of genes involved in vascular and hematopoietic 145 development downregulated in npas4l mutants at the 6-somite stage, confirming its role in the 146 early specification of endothelium and blood (Fig. S2A) . Surprisingly, we found that genes 147 involved in neural function were upregulated in npas4l mutants, suggesting that angioblasts, or 148 npas4l itself, may have a role in repressing neuronal gene expression at 6-somite stage (Fig.  149   S2B) . Murine NPAS4 is known to regulate synaptic function (Spiegel et al., 2014) , and npas4a 150 expression was previously described to be restricted to the zebrafish brain, similar to mammalian 151
Npas4 (Klaric et al., 2014) . We previously reported that npas4l was expressed specifically in the 152 LPM during early somitogenesis using in situ hybridization (ISH) (Reischauer et al., 2016) . 153
Nevertheless, neural progenitors might express levels of npas4l too low to detect by ISH. 154
Interestingly, a subset of genes regulated by npas4l, including gata2a and tal1, were found to be 155 Given the striking phenotype of npas4l mutants and the ability of Npas4l to potently activate its 160 target genes as early as 4 hpf (Fig. 1C) , we wanted to test whether Npas4l acts as a pioneer 161 transcription factor. Pioneer transcription factors bind to condensed chromatin and have the 162 ability to make it more accessible, enabling other factors to access their target sites Doi and Zaret, 2014). One possible approach to investigate this question is to assess accessible 164 chromatin in a mutant setting, using the Assay for Transposase-Accessible Chromatin coupled to 165 next generation sequencing (ATAC-seq) (Buenrostro et al., 2015; Doganli et al., 2017) . We 166 incrossed npas4l +/fish and genotyped single embryos at the 1-somite stage. Subsequently, we 167 performed ATAC-Seq on mutants and WT siblings (Fig. 2D) . We compared ATAC-seq data to 168
Npas4l ChIP-Seq results, and observed that the chromatin accessibility at Npas4l binding sites 169 was not affected in npas4l mutants compared to WT (Fig. 2F) . Interestingly, in a small subset of 170
Npas4l targets, chromatin accessibility was reduced, as in the case of lmo2, although the affected 171 regions do not appear to interact directly with Npas4l ( Fig. 2E) . The present data indicate that 7
Npas4l binds to open chromatin to recruit the transcriptional machinery, promoting the 173 expression of its target genes. Importantly, Npas4l might regulate chromatin state specifically in 174 angioblasts, and this effect might be diluted in the whole embryo analysis. 175 npas4l overexpression at tailbud stage promotes the expression of etv2 but not of cdh5 176
To test for genes that may be induced by npas4l at later stages, we generated and used a 177 heatshock inducible line (Fig. S4A) . Considering the physiological expression pattern of etv2, 178 tal1 and lmo2, we induced npas4l expression at tailbud (TB) stage, concomitantly with the 179 appearance of the first angioblast markers (Fig. S4B) . We performed qPCR at different time 180 points to identify the ideal time point when direct targets were induced, but secondary targets 181 were not affected. At 1 hour post heatshock (hph), etv2 upregulation was detectable while cdh5 182 expression, a known target of etv2, was not significantly upregulated ( Fig. S4C) . We performed 183 RNA-seq analysis at 1 hph, and could detect etv2 expression increasing by more than 2-fold 184 (Table I) . Notably, tal1 and lmo2 expression levels were also upregulated after heatshock, but 185 due to their high level of expression in WT, the induction of these genes was below 2-fold 186 (Table I) . 187 188 tspan18b as a novel gene potentially involved in vascular development 189
Following the generation and analysis of the individual datasets, we combined the obtained data 190 in order to investigate the mechanisms underlying npas4l function and identify new npas4l target 191 genes. The resulting Venn diagram includes the overexpression experiment, the transcriptome of 192 npas4l mutants at the 6-somite stage and the ChIP-Seq data, considering all genes whose TSS is 193 found within a 100kb window from at least one Npas4l binding site. As the Venn diagram 194 highlights (Fig. 3A) , using a threshold of 2-fold change, etv2 is the only gene consistently 195 present in all datasets. Notably, lmo2, tal1 and egfl7, despite being direct targets of Npas4l, are 196 not induced by npas4l overexpression at TB stage, due to their physiologically high expression 197
level at the stage of sample collection. According to our ChIP-Seq data, Npas4l does not seem to 198 bind to the promoter of sox7, although sox7 is present in all other datasets and it was previously 199 described to act downstream of etv2 (Wong et al., 2009 ). Our analysis aimed to identify novel 200 genes and intriguingly, a previously undescribed gene, si:dkey-121a11.3, was detected in most of 201 the datasets, although Npas4l does not appear to bind its proximal promoter (Table I) . We 202 therefore focused our attention on tspan18b, a gene induced by npas4l and with an Npas4l 203 binding site in its promoter (Table I) . tspan18 belongs to the tetraspanin family and it has been 204 reported to be expressed in the developing vasculature in chick (Fairchild and Gammill, 2013) 205 and mouse (Scialdone et al., 2016) . To study its function in zebrafish, we generated a mutant 206 line using CRISPR/Cas9 technology by targeting exon 4 and recovered a 16-nucleotide insertion 207 that leads to a premature stop codon after a 74 amino acid-long missense segment (Fig. S5) . 208
When crossed to the a Tg(fli1a:EGFP) background (Lawson and Weinstein, 2002) , we observed 209 defects in the formation of the intersegmental vessels at 36 hpf in tspan18 mutants (Fig. 3B) . 210
Notably, the phenotype observed was partially penetrant (Fig. 3C) , possibly due, at least in part, 211 to compensatory mechanisms described to occur following gene knockout (Rossi et al., 2015) . 212
In conclusion, our results represent a collection of genome-wide data that allow for the 213 identification of genes acting downstream of Npas4l in vivo. We foresee that the data generated 214 and the analyses performed in the present study will be a valuable resource for the scientific 215 community, especially those who aim to investigate not only EC specification, but also 216 hematopoietic and vascular development. In addition, the present study describes the molecular 217 mechanisms underlying Npas4l function by revealing its binding motif and its direct targets. The 218 analysis of npas4l target genes led to the identification and characterization of tspan18b, a novel 219 regulator of vascular development in fish, and future studies will be required to further 220 investigate the role of this gene in vascular development and function. 221 222 10 Hermkens, D. M., van Impel, A., Urasaki, A., Bussmann, J., Duckers, H. J. and Schulte-269
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